Pharma major Lupin announced the launch of its Tydemy™ Tablets (Drospirenone, Ethinyl Estradiol, Levomefolate Calcium, 3mg/0.03mg/0.451mg and Levomefolate Calcium, 0.451mg) having received an approval from the United States Food and Drug Administration (FDA) earlier.


Healthwise and GetWellNetwork® announced today they will partner in offering health education to health care providers and their patients. GetWellNetwork will add over 600 Healthwise patient education videos to its current suite of patient experience technologies that deliver Precision Engagement™ across the care continuum.


Scheer Partners, the leading provider of fully integrated commercial real estate services in the Washington and Baltimore metropolitan areas, announced today that it has negotiated on behalf of Supernus Pharmaceuticals, Inc., a 118,000-square-foot headquarters lease at 700 Quince Orchard Road, a building owned by the Rock Creek Fund.


This discussion covers how David arrived in Maryland, the role of MCEDC in the BioHealth Capital Region, and why Montgomery County is a great place to do business.

Before becoming the inaugural President and CEO of MCEDC, David was with the Central Florida Development Council, where as President and CEO, he achieved record-setting job creation and capital investment results. Previously, David was the Executive Director of the Winter Haven Economic Development Council in Florida. In Texas, he has held key marketing management positions in economic development and was an advertising agency owner in Austin.

Listen now on iTunes Google Play , and TuneIn


Freeman Hrabowski III, the university president and most notable dreamer at Maryland Baltimore County, didn’t close his eyes until 6 a.m. Saturday. He had too many text messages to answer, too many calls to take, too many voice mails to retrieve. He had too many people to hug, too many whys and hows to try to explain, too many Friday night thrills to relive.


Roche is buying out the rest of Flatiron Health for $1.9 billion, the companies said Thursday. The total investment for Roche, a drug maker based in Switzerland, is about $2.1 billion in cash since it already owned about 13% of Flatiron, a tech company that handles electronic health records and data mining specifically for cancer doctors, researchers and patients.


The Maryland Tech Council and SoBran are celebrating the transformational science coming out of Maryland and surrounding area by establishing the Innovation for Impact Prize. This is an added annual award at the Industry Awards Celebration. Tell us how your innovative research will impact the world one day and describe your research! Deadline to apply is April 17, 2018.


ETC (The Emerging Technology Centers), Baltimore City’s technology and innovation center and award-winning entrepreneur support organization, was ranked seventh, globally, in UBI’S World Incubator Summit Awards for World of Top Business Incubator – Collaborating with University.


Mosquitoes are bad news when it comes to the spread of malaria, a deadly disease which kills hundreds of thousands of people each year. We previously covered a range of approaches to cracking down on this problem — ranging from apps which track disease-carrying mosquitoes by listening to their buzz to a plan to release genetically engineered killer mosquitoes to hunt down their disease-carrying wild counterparts.


Mid Atlantic Bio Angels (MABA) announces today the initiation of a second closed-end investment pool (Pool II) funded by current, active MABA members, and the inaugural investment from that pool made into Israel-based POP Medical Solutions Ltd., which focuses on the treatment of pelvic organ prolapse (POP).


The Tech Council Innovation Network is the membership arm of the Wisconsin Technology Council. It exists to serve as an educational and networking resource for entrepreneurs and people who work for high-growth firms, large and small. In association with the Tech Council, these programs focus on the needs and challenges faced by new and growing technology-based businesses in Wisconsin.

When you become a member, your membership applies to all chapters, statewide.  Membership is for one year starting with the month you join.


Wed, Apr 11, 2018 2:00 PM - 3:30 PM EDT

USDA ARS and the USDA SBIR program formed a partnership to encourage USDA SBIR applicants to develop research collaborations with ARS scientists and/or to license ARS technologies. The purpose is to increase the likelihood of success by providing both money and technologies to small U.S. businesses. The relevant language in the SBIR’s “Request for Application” states: "Additional factors that will be considered in the review process include whether an application involves a Cooperative Research and Development Agreement (CRADA) with a USDA laboratory, or a license to a USDA technology, or is a resubmission.”


Older people need more medicine. That rule of life is no secret to pharmaceutical companies across the globe. Many also realize that Japan’s rapidly aging population presents a unique business opportunity. Japan remains the world’s second-biggest pharmaceuticals market, behind only the United States and China. The Japanese market also is expected to grow annually. The lessons learned there will be critical as the population grows older in many other markets.


The year 2017 marked yet another exciting period of innovation and growth for the University of Maryland (UMD) research community, with over 170 inventions disclosed and 52 patented, 46 technologies licensed, and the receipt of the largest investment in UMD history in total of $219.5 million from the A. James and Alice B. Clark Foundation. Researchers broke barriers in fields related to agriculture, information management, biotechnology, and energy, making discoveries and inventing technologies that have the potential to make positive impacts on the planet and on people’s lives around the globe.


Join ISPE Chesapeake Bay Area Chapter, Maryland Tech Council, BioHealth Innovation and ByteGrid for a one day Life Sciences Cloud & Infrastructure Conference.

Listen to speakers, including Krishna Ghosh, Ph. D., Senior Policy Advisor at the Food and Drug Administration, and the co-chairs of the GAMP Cloud Special Interest Group and get a behind-the-scenes data center tour of ByteGrid’s flagship Silver Spring facility.

You’ll also get valuable insights into cloud adoption in the regulated Life Sciences industry, hear about updates to the revised ISPE GAMP Good Practice Guide on IT Infrastructure and much more!

The agenda and speakers are listed here:


The Innovative Molecular Analysis Technology Development for Cancer Research and Clinical Care (SBIR-IMAT) solicitation is a companion SBIR funding opportunity announcement to the NCI Innovative Molecular Analysis Technologies (IMAT) Program aimed at the inception, development, integration, and application of novel and emerging technologies in support of cancer research, treatment, diagnosis, and prevention.


TEDCO, Maryland’s economic engine for technology companies, inducts ClearMask into its mdPACE program to assist in bringing its life-changing innovation to market. Baltimore-based, ClearMask LLC is the developer of the country’s first, full-face transparent surgical mask designed to help healthcare entities reduce medical errors caused by miscommunication and provide a better experience for deaf patients and other patient groups who heavily rely on visual cues, including children, limited English proficiency patients, and immunosuppressed patients who cannot see the smiles of their loved ones and care team.


23andMe, Inc., the leading personal genetics company, today received the first-ever FDA authorization for a direct-to-consumer genetic test for cancer risk. The authorization allows 23andMe to provide customers, without a prescription, information on three genetic variants found on the BRCA1 and BRCA2 genes known to be associated with higher risk for breast, ovarian and prostate cancer.